HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Kamal A. Mansour Richard S. Downey Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mansour, K. A. Articles by Downey, R. S. Search for Related Content PubMed PubMed Citation Articles by Mansour, K. A. Articles by Downey, R. S.

Ann Thorac Surg 1989;48:201-204
© 1989 The Society of Thoracic Surgeons

---

Articles

Esophageal carcinoma: Surgery without preoperative adjuvant chemotherapy

Division of Thoracic and Cardiovascular Surgery, The Joseph B. Whitehead Department of Surgery, Emory University School of Medicine, Atlanta, Georgia USA

^_* Address reprint requests to Dr Mansour, The Emory Clinic, 1365 Clifton Rd, NE, Atlanta, Georgia 30322.

Our experience with 100 consecutive patients with esophageal carcinoma treated with surgical intervention as the primary method of therapy between 1967 and 1987 was reviewed. Preoperative chemotherapy was not administered by us. Follow-up was complete for all 160 patients. Twelve percent of tumors were in the proximal third of the esophagus, 21% were in the middle third, and 67% were in the distal third. Adenocarcinoma accounted for 44% of all tumors, squamous cell for 55%, and adenosquamous for 1%. Six patients were in stage I, 14 were in stage II, and 80 were in stage III; no patient was in stage IV. Surgical procedures included 85 esophagogastrectomies with primary anastomoses, 11 with colon interposition, and 4 with Roux-en-Y small-bowel interposition. Six patients had radical laryngopharyngo-esophagectomy with gastric or colopharyngeal anastomosis. Operative mortality was 3%. The mean survival of stage I patients was 182 months; stage II patients, 25 months; and stage III patients, 18 months. Our data show that surgical resection without preoperative adjuvant chemotherapy remains the cornerstone of therapy for patients with carcinoma of the esophagus.

This article has been cited by other articles:

				M. M. DeCamp Jr, S. J. Swanson, and M. T. Jaklitsch Esophagectomy After Induction Chemoradiation* Chest, December 1, 1999; 116(2011): 466S - 469S. [Abstract] [Full Text] [PDF]

				K. A. Mansour, V. H. Thourani, and W. A. Cooper Esophageal Carcinoma: Surgery Without Preoperative Adjuvant Chemotherapy Ann. Thorac. Surg., May 1, 1998; 65(5): 1492 - 1493. [Full Text] [PDF]

				K. S. Naunheim, P. J. Petruska, T. S. Roy, J. M. Schlueter, H. Kim, and A. E. Baue Multimodality therapy for adenocarcinoma of the esophagus Ann. Thorac. Surg., May 1, 1995; 59(5): 1085 - 1091. [Abstract] [PDF]

				K. S. Naunheim, J. Hanosh, J. Zwischenberger, M. W. Turrentine, K. A. Kesler, L. B. Reeder, M. K. Ferguson, and A. E. Baue Esophagectomy in the septuagenarian Ann. Thorac. Surg., October 1, 1993; 56(4): 880 - 884. [Abstract] [PDF]

				K. A. Morton, S. V. Karwande, R. Kim Davis, F. L. Datz, and R. E. Lynch Gastric emptying after gastric interposition for cancer of the esophagus or hypopharynx Ann. Thorac. Surg., May 1, 1991; 51(5): 759 - 763. [Abstract] [PDF]

				K. A. Mansour, A. L. Picone, and J. J. Coleman III Surgery for high cervical esophageal carcinoma: Experience with 11 patients Ann. Thorac. Surg., April 1, 1990; 49(4): 597 - 602. [Abstract] [PDF]